CorMedix (CRMD) EBT Margin (2013 - 2025)

CorMedix's (CRMD) quarterly EBT Margin came in at 43.89% in Q4 2025, down 6034.0% year-on-year from 0.74% in Q4 2024, and down 12.96% quarter-over-quarter from 50.42% in Q3 2025.

CorMedix (CRMD) EBT Margin (2013 - 2025) Analysis & Trends

CorMedix has disclosed EBT Margin across 12 years of filings, most recently posting 43.89% for Q4 2025.

  • EBT Margin for Q4 2025 came in at 43.89%, down 6034.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 48.13% (up 4872.0% YoY), and the FY2025 annual result was 48.13%, up 4872.0% from the prior year.
  • EBT Margin came in at 43.89% for Q4 2025 at CorMedix, down from 50.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 104.23% in Q4 2024 to a low of 100538.67% in Q3 2022.
  • The 4-year median for EBT Margin is 8171.25% (2021), against an average of 25099.03%.
  • Peak annual rise in EBT Margin reached 3328633 bps in 2022, while the deepest fall reached 8381393 bps in 2022.
  • CorMedix's EBT Margin stood at 13814.54% in 2021, then slumped by 100 bps to 27637.7% in 2022, then jumped by 100 bps to 104.23% in 2024, then tumbled by 58 bps to 43.89% in 2025.
  • The last three EBT Margin figures came in at 43.89% (Q4 2025), 50.42% (Q3 2025), and 51.21% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 41.95%
9 Abivax 91.71 Bn 91.71 Bn - -
10 CorMedix 631,378.03 -154.57 Mn 107.31 Mn 43.89%

Historic Data

Download Data
DateValue
Dec 31, 2025 43.89%
Sep 30, 2025 50.42%
Jun 30, 2025 51.21%
Mar 31, 2025 52.82%
Dec 31, 2024 104.23%
Sep 30, 2024 -24.24%
Jun 30, 2024 -1,755.51%
Dec 31, 2022 -27,637.70%
Sep 30, 2022 -100,538.67%
Jun 30, 2022 -38,537.88%
Mar 31, 2022 -91,985.18%
Dec 31, 2021 -13,814.54%
Sep 30, 2021 -22,498.86%
Jun 30, 2021 -71,824.21%
Mar 31, 2021 -8,171.25%
Dec 31, 2020 -10,925.34%
Sep 30, 2020 -7,096.05%
Jun 30, 2020 -54,441.52%
Mar 31, 2020 -7,500.40%
Dec 31, 2019 -21,406.83%